These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26724375)

  • 1. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
    Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
    Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
    Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
    Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.
    Charif R; Granotier-Beckers C; Bertrand HC; Poupon J; Ségal-Bendirdjian E; Teulade-Fichou MP; Boussin FD; Bombard S
    Chem Res Toxicol; 2017 Aug; 30(8):1629-1640. PubMed ID: 28657713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
    Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
    Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
    Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
    Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
    Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
    Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.
    Riou JF; Guittat L; Mailliet P; Laoui A; Renou E; Petitgenet O; Mégnin-Chanet F; Hélène C; Mergny JL
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2672-7. PubMed ID: 11854467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response.
    Che T; Chen SB; Tu JL; Wang B; Wang YQ; Zhang Y; Wang J; Wang ZQ; Zhang ZP; Ou TM; Zhao Y; Tan JH; Huang ZS
    J Med Chem; 2018 Apr; 61(8):3436-3453. PubMed ID: 29618208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
    Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF
    J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
    Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
    Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of studying telomere damage induced by quadruplex-ligand complexes.
    Rizzo A; Salvati E; Biroccio A
    Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
    Pennarun G; Granotier C; Gauthier LR; Gomez D; Hoffschir F; Mandine E; Riou JF; Mergny JL; Mailliet P; Boussin FD
    Oncogene; 2005 Apr; 24(18):2917-28. PubMed ID: 15735722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Cancer by Targeting Telomeres and Telomerase.
    Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
    Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
    Hu MH; Lin XT; Liu B; Tan JH
    Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.